Related Experiment Videos
A withdrawal syndrome after abrupt discontinuation of alprazolam
The American Journal of Psychiatry
|January 1, 1985
Abstract:
A patient who received therapeutic doses of alprazolam for 8 weeks experienced a withdrawal syndrome beginning 18 hours after its abrupt discontinuation. Short-acting and minimally sedating benzodiazepines may have increased potential for withdrawal reactions.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Project SATURN- a real-world evidence data collaboration with existing European datasets in Osteogenesis Imperfecta to support future therapies.
Orphanet journal of rare diseases·2024
A comparison of standard two-dimensional ultrasound to three-dimensional volume sonography for routine second-trimester fetal imaging.
Journal of perinatology : official journal of the California Perinatal Association·2017
The Hysterical personality.
Postgraduate medicine·2016
Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2014
The Longevity of Mental Health Apps: A Survival Analysis of the Largest Mental Health App Database.
The American journal of psychiatry·2026
Comparison of Long-Acting Injectable and Oral Antipsychotics in Bipolar Disorder.
The American journal of psychiatry·2026
New Horizons in the Development of Treatments for Substance Use Disorders.
The American journal of psychiatry·2026
The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions.
The American journal of psychiatry·2026
Hippocampal Dentate Gyrus Plasticity and Its Association With Dimensional Clinical Improvement Across Four Depression Treatment Interventions.
The American journal of psychiatry·2026
Updated total calcium reference intervals for Abbott Alinity c using Calcium2 reagents.
Clinical biochemistry·2026
Evaluation of a new non-competitive chemiluminescent immunoassay for 25-OH vitamin D measurement.
Diagnosis (Berlin, Germany)·2026
Development and Validation of an LC-MS/MS-Based Screening Method for Determination of Salbutamol in Urine for Doping Control Using a Surrogate Analyte Approach with Stable Isotope-Labeled Salbutamol (Salbutamol-d9).
Iranian journal of pharmaceutical research : IJPR·2026